These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38648403)

  • 21. Kinetics of viral RNA, immunoglobulin-M & G antibodies in Kyasanur forest disease.
    Yadav PD; Gurav YK; Shete AM; Jain R; Nyayanit DA; Pardeshi PG; Viswanathan R; Chiplunkar TR; Awate P; Majumdar TP; Sahay RR; Mourya DT
    Indian J Med Res; 2019 Aug; 150(2):186-193. PubMed ID: 31670274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical, clinicopathologic, and hematologic features of Kyasanur Forest disease.
    Pavri K
    Rev Infect Dis; 1989; 11 Suppl 4():S854-9. PubMed ID: 2665018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical & epidemiological significance of Kyasanur forest disease.
    Munivenkatappa A; Sahay RR; Yadav PD; Viswanathan R; Mourya DT
    Indian J Med Res; 2018 Aug; 148(2):145-150. PubMed ID: 30381537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and laboratory profile of patients with Kyasanur forest disease: A single-centre study of 192 patients from Karnataka, India.
    Gupta N; Chunduru K; Safeer K M; Saravu K
    J Clin Virol; 2021 Feb; 135():104735. PubMed ID: 33493988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kyasanur forest disease.
    Holbrook MR
    Antiviral Res; 2012 Dec; 96(3):353-62. PubMed ID: 23110991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experiences of Indian Council of Medical Research with tick-borne zoonotic infections: Kyasanur Forest disease & Crimean-Congo haemorrhagic fever in India with One Health focus.
    Mourya DT; Yadav PD; Patil DY; Sahay RR; Rahi M
    Indian J Med Res; 2021 Mar; 153(3):339-347. PubMed ID: 33906997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kyasanur forest disease: an epidemiological view in India.
    Pattnaik P
    Rev Med Virol; 2006; 16(3):151-65. PubMed ID: 16710839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spatial distribution of Haemaphysalis species ticks and human Kyasanur Forest Disease cases along the Western Ghats of India, 2017-2018.
    Naren Babu N; Jayaram A; Hemanth Kumar H; Pareet P; Pattanaik S; Auti AM; Abdulmajeed J; Maity H; Devadiga S; Bhandari Y; Agre Deepchand H; Shakir M; Kumar N; Arunkumar G
    Exp Appl Acarol; 2019 Mar; 77(3):435-447. PubMed ID: 30809731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kyasanur forest disease: a state-of-the-art review.
    Gupta N; Wilson W; Neumayr A; Saravu K
    QJM; 2022 Jun; 115(6):351-358. PubMed ID: 33196834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology, Pathogenesis, and Control of a Tick-Borne Disease- Kyasanur Forest Disease: Current Status and Future Directions.
    Shah SZ; Jabbar B; Ahmed N; Rehman A; Nasir H; Nadeem S; Jabbar I; Rahman ZU; Azam S
    Front Cell Infect Microbiol; 2018; 8():149. PubMed ID: 29868505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phylogeography of Kyasanur Forest Disease virus in India (1957-2017) reveals evolution and spread in the Western Ghats region.
    Yadav PD; Patil S; Jadhav SM; Nyayanit DA; Kumar V; Jain S; Sampath J; Mourya DT; Cherian SS
    Sci Rep; 2020 Feb; 10(1):1966. PubMed ID: 32029759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kyasanur forest disease virus breaking the endemic barrier: An investigation into ecological effects on disease emergence and future outlook.
    Ajesh K; Nagaraja BK; Sreejith K
    Zoonoses Public Health; 2017 Nov; 64(7):e73-e80. PubMed ID: 28220635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics of human infection with Kyasanur Forest Disease Virus.
    Devadiga S; Arunkumar G
    J Infect; 2022 Aug; 85(2):161-166. PubMed ID: 35609707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Species distribution and ecological suitability analysis for potential tick vectors of Kyasanur forest disease in the Western Ghats of Kerala.
    Rathinam B; Sidhik S
    Med Vet Entomol; 2022 Mar; 36(1):38-42. PubMed ID: 34558682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical study of 100 cases of Kyasanur Forest disease with clinicopathological correlation.
    Adhikari Prabha MR; Prabhu MG; Raghuveer CV; Bai M; Mala MA
    Indian J Med Sci; 1993 May; 47(5):124-30. PubMed ID: 8225455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The species distribution of ticks & the prevalence of Kyasanur forest disease virus in questing nymphal ticks from Western Ghats of Kerala, South India.
    Balasubramanian R; Yadav PD; Sahina S; Nadh VA
    Indian J Med Res; 2021 May; 154(5):743-749. PubMed ID: 35532592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kyasanur Forest disease, India, 2011-2012.
    Kasabi GS; Murhekar MV; Yadav PD; Raghunandan R; Kiran SK; Sandhya VK; Channabasappa GH; Mishra AC; Mourya DT; Mehendale SM
    Emerg Infect Dis; 2013 Feb; 19(2):278-81. PubMed ID: 23343570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Plantation Induced Forest Degradation on the Outbreak of Emerging Infectious Diseases-Wayanad District, Kerala, India.
    Saha K; Ghatak D; S Muralee NS
    Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and Laboratory Diagnostic Features of Kyasanur Forest Disease: A Study From Wayanad, South India.
    Gladson V; Moosan H; Mathew S; P D
    Cureus; 2021 Dec; 13(12):e20194. PubMed ID: 35004016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kyasanur Forest disease outbreak and vaccination strategy,Shimoga District, India, 2013-2014.
    Kiran SK; Pasi A; Kumar S; Kasabi GS; Gujjarappa P; Shrivastava A; Mehendale S; Chauhan LS; Laserson KF; Murhekar M
    Emerg Infect Dis; 2015 Jan; 21(1):146-9. PubMed ID: 25531141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.